Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France

Hiligsmann, M; Reginster, Jean-Yves

Paper published in a journal (Scientific congresses and symposiums)

Hiligsmann, M; Reginster, Jean-Yves

2019 • In Osteoporosis International, 30 (S2), p. 182

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/238300

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France.pdf

Publisher postprint (656.39 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Public health, health care sciences & services

Author, co-author :

Hiligsmann, M

Reginster, Jean-Yves ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Language :

English

Title :

Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France

Publication date :

July 2019

Event name :

World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases

Event organizer :

WCO-IOF-ESCEO

Event place :

Paris, France

Event date :

du 4 au 7 avril 2019

Audience :

International

Journal title :

Osteoporosis International

ISSN :

0937-941X

eISSN :

1433-2965

Publisher :

Springer, Germany

Volume :

Issue :

Pages :

S182

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://dx.doi.org/10.1007/s00198-018-04821-7

Available on ORBi :

since 23 July 2019

Statistics

Number of views

40 (2 by ULiège)

Number of downloads

2 (0 by ULiège)

More statistics